A Phase IIb Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients With T790M Mutation Positive
Clinical trial NCT03812809 · COMPLETED
Trial details
- NCT number
- NCT03812809
- Sponsor
- Beta Pharma Shanghai
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-05
- Primary completion
- 2022-01-24
- Enrollment
- 226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.